Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABIGAIL: Avastin Biomarkers in Advanced NSCLC
NCT00700180Phase 2Completed
- Sponsor
- Roche
- Start
- Sep 2008
- Primary completion
- Sep 2012
- Modality
- Monoclonal Antibodies
- Countries
- 16
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by Roche. Started Sep 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00700180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700180.